The Star, , Controversial Aids-drug firm to be sold off
By Nalisha Kalideen
which manufactured a controversial anti-Aids drug that was tested on Tanzanian
soldiers, is being auctioned.
auction will take place on Wednesday.
company, a subsidiary of the Central Energy Fund, was mired in controversy last
year when it tried to distribute the coal-based drug Oxihumate-K to HIV and Aids
patients without permission from the Department of Health.
'What will be on auction is all the research done'
claimed that it had been given permission, but the department said it had
withdrawn permission for distribution over concern about the drug's high chrome
had said it was unacceptable to distribute the capsules, filled with black
powder that supposedly boosted immunity, because clinical trials had not been
was then tested on HIV-positive Tanzanian soldiers and civilians.
will be auctioned in its entirety, including the laboratory and other facilities
at the Council for Scientific and Industrial Research in
auction also includes the property rights to the drug Oxihumate-K and the
results of its clinical trials.
will be selling the intellectual property rights of the company. There are 57
different individual rights that are downscaled into 11 projects. What will be
on auction is all the research done," said Chico da Silva, of auction
The auction is set to raise about R30-million - meaning an expected R100-million loss to taxpayers.